JPS5293753A - Process for preparing intermediate of novel prostaglandine homolog - Google Patents

Process for preparing intermediate of novel prostaglandine homolog

Info

Publication number
JPS5293753A
JPS5293753A JP14060776A JP14060776A JPS5293753A JP S5293753 A JPS5293753 A JP S5293753A JP 14060776 A JP14060776 A JP 14060776A JP 14060776 A JP14060776 A JP 14060776A JP S5293753 A JPS5293753 A JP S5293753A
Authority
JP
Japan
Prior art keywords
prostaglandine
homolog
novel
preparing intermediate
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP14060776A
Other languages
Japanese (ja)
Inventor
Rosu Jiyonson Maikeru
Yurugen Erunsuto Hesu Hansu
Ken Shiyaafu Toomasu
Shinfu Bindora Jiyashitsuto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of JPS5293753A publication Critical patent/JPS5293753A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/60Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4056Esters of arylalkanephosphonic acids
    • C07F9/4059Compounds containing the structure (RY)2P(=X)-(CH2)n-C(=O)-(CH2)m-Ar, (X, Y = O, S, Se; n>=1, m>=0)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
    • C07F9/655345Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a five-membered ring
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B63SHIPS OR OTHER WATERBORNE VESSELS; RELATED EQUIPMENT
    • B63BSHIPS OR OTHER WATERBORNE VESSELS; EQUIPMENT FOR SHIPPING 
    • B63B2211/00Applications
    • B63B2211/02Oceanography

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
JP14060776A 1972-07-13 1976-11-22 Process for preparing intermediate of novel prostaglandine homolog Pending JPS5293753A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27122072A 1972-07-13 1972-07-13

Publications (1)

Publication Number Publication Date
JPS5293753A true JPS5293753A (en) 1977-08-06

Family

ID=23034697

Family Applications (4)

Application Number Title Priority Date Filing Date
JP48079214A Expired JPS5241257B2 (en) 1972-07-13 1973-07-13
JP14060576A Pending JPS5297958A (en) 1972-07-13 1976-11-22 Production of intermediate of 155substituteddomegaa pentanoprostaglandine
JP14060676A Pending JPS52122349A (en) 1972-07-13 1976-11-22 Process for preparing tntermediate of 155substituteddomegaa pentanoprostagladines
JP14060776A Pending JPS5293753A (en) 1972-07-13 1976-11-22 Process for preparing intermediate of novel prostaglandine homolog

Family Applications Before (3)

Application Number Title Priority Date Filing Date
JP48079214A Expired JPS5241257B2 (en) 1972-07-13 1973-07-13
JP14060576A Pending JPS5297958A (en) 1972-07-13 1976-11-22 Production of intermediate of 155substituteddomegaa pentanoprostaglandine
JP14060676A Pending JPS52122349A (en) 1972-07-13 1976-11-22 Process for preparing tntermediate of 155substituteddomegaa pentanoprostagladines

Country Status (25)

Country Link
JP (4) JPS5241257B2 (en)
AR (2) AR209064A1 (en)
AT (1) AT367033B (en)
BE (1) BE802231A (en)
CA (1) CA1041495A (en)
CH (1) CH593254A5 (en)
CS (1) CS201027B2 (en)
DD (2) DD109210A5 (en)
DE (1) DE2334945A1 (en)
ES (4) ES416865A1 (en)
FI (1) FI57583C (en)
FR (1) FR2192834B1 (en)
GB (1) GB1446341A (en)
HU (4) HU171158B (en)
IE (1) IE37909B1 (en)
IL (2) IL42691A (en)
IN (1) IN138789B (en)
LU (1) LU68015A1 (en)
NL (1) NL7309792A (en)
NO (2) NO143741C (en)
PH (1) PH11461A (en)
SE (3) SE7705947L (en)
SU (4) SU644384A3 (en)
YU (1) YU187773A (en)
ZA (1) ZA734769B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1386146A (en) * 1972-05-03 1975-03-05 Ici Ltd Cyclopentane derivatives
DE2463432C2 (en) * 1974-04-03 1987-06-19 Hoechst Ag, 6230 Frankfurt, De
DE2416193C2 (en) 1974-04-03 1985-08-14 Hoechst Ag, 6230 Frankfurt Prostaglandin analogs, processes for their preparation and their use as cytoprotective agents
ZA747723B (en) * 1974-12-11 1976-11-24 Pfizer 11-desoxy-15-substituted-omega-pentanor prostaglandins
US4149006A (en) * 1977-01-24 1979-04-10 G. D. Searle & Co. Prostaglandin derivatives having alkynyl, hydroxy and aryloxy junctions in the 2β side chain
GB8329559D0 (en) * 1983-11-04 1983-12-07 Erba Farmitalia Furyl derivatives of 16-substituted prostaglandins preparations
SE9002596D0 (en) * 1990-08-08 1990-08-08 Pharmacia Ab A METHOD OF SYNTHESIS OF PROSTAGLANDIN DERIVATIVES
US6602900B2 (en) 1992-09-21 2003-08-05 Allergan, Inc. Cyclopentane heptan(ENE)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
US5972991A (en) * 1992-09-21 1999-10-26 Allergan Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
KR100578616B1 (en) * 2004-07-23 2006-05-10 한미약품 주식회사 Method for the preparation of d-erythro-2,2-difluoro-2-deoxy-1-oxoribose
BR112016013594A8 (en) * 2013-12-13 2020-05-19 Allergan Inc crystalline forms of a dihydroxy cyclopentyl alpha compound, omega-disubstituted, pharmaceutical composition, methods for preparing and using them

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4954349A (en) * 1972-06-02 1974-05-27
JPS4975558A (en) * 1972-05-03 1974-07-20

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1324737A (en) * 1970-11-02 1973-07-25 Upjohn Co Prostaglandins and the preparation thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4975558A (en) * 1972-05-03 1974-07-20
JPS4954349A (en) * 1972-06-02 1974-05-27

Also Published As

Publication number Publication date
JPS4992053A (en) 1974-09-03
AR214383A1 (en) 1979-06-15
SE7705946L (en) 1977-05-20
ZA734769B (en) 1974-06-26
ES437038A1 (en) 1977-01-01
SU645564A3 (en) 1979-01-30
SE7705945L (en) 1977-05-20
DD109210A5 (en) 1974-10-20
IL42691A0 (en) 1973-10-25
AT367033B (en) 1982-05-25
ES437039A1 (en) 1977-01-01
DD116459A5 (en) 1975-11-20
IL42691A (en) 1979-07-25
FR2192834A1 (en) 1974-02-15
CS201027B2 (en) 1980-10-31
CA1041495A (en) 1978-10-31
NL7309792A (en) 1974-01-15
JPS5297958A (en) 1977-08-17
HU172058B (en) 1978-05-28
ES416865A1 (en) 1976-03-01
SE7705947L (en) 1977-05-20
IN138789B (en) 1976-04-03
PH11461A (en) 1978-02-01
AR209064A1 (en) 1977-03-31
BE802231A (en) 1974-01-14
SU584791A3 (en) 1977-12-15
JPS52122349A (en) 1977-10-14
FR2192834B1 (en) 1979-04-06
HU171156B (en) 1977-11-28
ATA620773A (en) 1981-10-15
NO143741C (en) 1981-04-08
JPS5241257B2 (en) 1977-10-17
HU171158B (en) 1977-11-28
IE37909L (en) 1974-01-13
HU171946B (en) 1978-04-28
IE37909B1 (en) 1977-11-09
YU187773A (en) 1982-02-25
NO144830B (en) 1981-08-10
SU644384A3 (en) 1979-01-25
AU5778473A (en) 1975-01-09
CH593254A5 (en) 1977-11-30
LU68015A1 (en) 1974-01-21
GB1446341A (en) 1976-08-18
SU645563A3 (en) 1979-01-30
NO144830C (en) 1981-11-18
IL50308A0 (en) 1976-10-31
FI57583B (en) 1980-05-30
FI57583C (en) 1980-09-10
NO143741B (en) 1980-12-29
ES437037A1 (en) 1977-01-01
NO743492L (en) 1974-01-15
DE2334945A1 (en) 1974-03-07

Similar Documents

Publication Publication Date Title
YU36368B (en) Process for preparing substituted chloroacetanilides
JPS5257147A (en) Process for preparing omegaasubstituted pentanor prostagladines intermediates
CH614188A5 (en) Process for the preparation of novel aminophenylethanolamines
YU228873A (en) Process for preparing novel benzoyl-benzofuran derivatives
JPS5293753A (en) Process for preparing intermediate of novel prostaglandine homolog
PH9369A (en) Process for preparing derivatives of 1-phenoxy-3-amino-propane-2-ol
SU725559A3 (en) Method of preparing benzofuran derivatives
EG11021A (en) Process for preparing of new penicillins
YU121973A (en) Process for obtaining silylesters of azetidine-2-sulfenate
EG11062A (en) Process for preparing of new penicillins
BG24661A3 (en) Method of preparing d-1-11-deoxoprostaglandine-e
KR780000196B1 (en) Process for preparation of oxazoles
HU171945B (en) Process for preparing p-biphenylyl-esters of 16-phenyl-11,15-tetrahydro-pyranyloxy-omega-tetranor-prostaglandin
KR780000029B1 (en) Process for preparing novel benzyl-pyrimidines
YU36156B (en) Process for preparing novel phenyl-formamides
YU299579A (en) Process for obtaining novel derivatives of aminoimidazoloisoquinoline
CS183747B2 (en) Method of preparing novel 1-p-/2-substituted aminovinyl/phenoxy-2-hydroxy-3-aminopropanes
YU39295B (en) Process for preparing substituted chloroacetylanilides
EG11137A (en) Process for preparing of neue 2-benzoyl-3-amino pyridine
YU35595B (en) Process for preparing novel lactams
KR780000551B1 (en) Process for preparation of dichlor benzaldehydoximcarbonate
EG11435A (en) Process for preparation of n(1-ethyl-2-pyrrolidylmethyl)-2-methoxy-5-ethylsulphonyl-benzamide
BG24663A3 (en) Method of preparing succinylsuccinic acid dieste s
KR780000194B1 (en) Process for preparation of monohaloacetylhalide
CS179977B2 (en) Method for producing novel derivatives of benzocycloheptathiophenone